Winter 2010 - Plasma

Hemophiliacs Eligible for College Scholarships

College students with hemophilia or a related bleeding disorder and their family members are eligible to apply for the Eric Dostie Memorial College Scholarship. The scholarship will award $1,000 each to 10 students who can best demonstrate scholastic achievement, community service and financial need. Applicants must submit an essay describing how their education will be used to serve humankind and to encourage self-improvement and enrichment.

The annual scholarship is made possible by NuFACTOR, the specialty pharmacy subsidiary of FFF Enterprises Inc., Temecula, Calif., the nation’s leading distributor of critical-care plasma products, antihemophilic factors and preventive vaccines. The scholarship was created to honor the memory of Eric Steven Dostie of Easthampton, Mass., a 5-year-old boy with hemophilia, who was tragically murdered on August 27, 1994. Eric’s brief life forever touched many others with joy, humor and unending love. Eric used to tell his parents and grandparents that he might grow up to be a scientist and invent a cure for hemophilia in the form of a “chocolate pill.” Although Eric’s dream will never be realized, it has the chance to live on in the recipients of the award, who pursue a college degree to broaden their education and career opportunities.

To be eligible to apply, students must be citizens of the United States and enrolled full-time in an accredited twoor four-year college program. The scholarship application deadline is March 1, 2010. An application can be accessed at www.NuFACTOR.com.

BSTQ Staff
BioSupply Trends Quarterly [BSTQ] is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace. With timely and critical information, each themed issue covers topics ranging from product breakthroughs, industry insights and innovations, up-to-the-minute news on the latest clinical trials, accessibility, and service and safety concerns.